
Five questions for Dr. Mingsum Lee
Mingsum Lee, MD, PhD, has been named as the 2025 Southern California Permanente Medical Group Physician Researcher of the Year. Commenting about her selection for the award, one nominator said Dr. Lee “is a true quadruple threat as an exceptional clinician, educator, administrator, and prolific ...
Featured News

Los Angeles wildfires increased virtual medical visits
In January 2025, when wildfires swept from the foothills above Los Angeles into the densely populated urban areas below, evacuations ensued and a thick layer of smoke spread across the region. Air quality ...

Predicting heart issues among breast cancer survivors
Researchers have developed a new risk calculation model to help predict the risks of heart problems for breast cancer survivors. Their research was published in JAMA Oncology in October 2025. “There ...

Diabetes medications vary in ability to reduce heart attacks and strokes
A new study led by Kaiser Permanente researchers compared how well 4 different types of glucose-lowering medications reduced the risk of heart attack and stroke for patients with type 2 diabetes, providing ...
Five questions for … Dr. Annette Langer-Gould
December 20, 2023Annette Langer-Gould, MD, PhD, is a translational neuroscientist with the Southern California Permanente Medical Group. She treats people with multiple sclerosis (MS) at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould joined Kaiser Permanente in 2009. Her research aims to deepen understanding of MS while improving quality of care. Recently, she co-authored an editorial in ...Read more...COVID bivalent booster protects well against hospitalization
December 4, 2023A Kaiser Permanente study shows the Pfizer-BioNTech BNT162b2 BA.4/5 bivalent mRNA vaccine helped protect against a range of COVID symptoms and was effective against the COVID XBB strain sublineages. The most substantial benefit of the bivalent vaccine booster was keeping people out of the hospital and keeping people from becoming critically ill. The study was ...Read more...Kaiser Permanente Southern California to lead CDC-funded center to improve outbreak and disease prediction
October 18, 2023Kaiser Permanente Southern California has been tapped to lead an innovation center that will develop advanced modeling approaches to better predict disease outbreaks and prepare the United States for future public health emergencies. The center is 1 of 13 sites that will form the Outbreak Analytics and Disease Modeling Network, a national initiative funded by the ...Read more...Diabetes increased among kids during pandemic
September 25, 2023A study of more than 1 million Kaiser Permanente members ages 19 and younger found that rates of both type 1 and type 2 diabetes increased among children during the COVID-19 pandemic, particularly for those ages 10 and older, male children, and children in specific racial and ethnic groups. The study was published September 21, ...Read more...Kaiser Permanente cancer survival rates higher
September 25, 2023Kaiser Permanente had better 5-year survival rates among breast, colorectal, and lung cancer patients compared to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) estimates, according to research published in September 2023 in The Permanente Journal. Researchers in all 8 Kaiser Permanente regions worked together on this study. They compared the occurrence of cancer ...Read more...Five questions for … Dr. Emily Rayens
September 18, 2023Emily Rayens, PhD, MPH, is a postdoctoral research fellow in the Division of Epidemiologic Research of the Department of Research & Evaluation. Her research interests include infectious diseases and vaccine efficacy and safety. She began her fellowship at Kaiser Permanente in 2023, but it is her third year as a postdoctoral fellow. She was previously ...Read more...Five questions for … Dr. Titilola Labisi
September 18, 2023Titilola Labisi, PhD, MHA, MPH, is a public health researcher and a postdoctoral research fellow in the Division of Behavioral Research of the Department of Research & Evaluation. She joined the department in 2022. Her research interests include community-engaged research, health disparities, and health behaviors related to sex, diet, and physical activity. She previously worked ...Read more...Five questions for … Dr. Nehaa Khadka
September 18, 2023Nehaa Khadka, PhD, MPH, is a maternal/child health epidemiologist and postdoctoral research fellow in the Division of Epidemiologic Research of the Department of Research & Evaluation. Her research interests include perinatal epidemiology, reproductive health, and health disparities. She began her fellowship in June 2023. While pursuing her doctorate degree at the UCLA Fielding School of ...Read more...Five questions for … Dr. Rudy Patrick
September 18, 2023Rudy Patrick, PhD, MPH, is an epidemiologist with research expertise in HIV epidemiology and social network among sexual and gender minorities. He is the fourth Epidemic Intelligence Service officer with the Centers for Disease Control and Prevention to work at the Department of Research & Evaluation. Before joining Kaiser Permanente, Dr. Patrick was a supervisory epidemiologist ...Read more...Interns make incredible contributions to research
September 15, 2023When Cheyne Hoke began in the Department of Research & Evaluation’s internship program in June 2023, she was a University of California, Berkeley MPH candidate focused on epidemiology and biostatistics. As an intern she spent her summer months working remotely with Kaiser Permanente researchers on what some might consider a “geeky” endeavor: SAS EG extracting, ...Read more...

